期刊文献+

术中B超引导下行肝癌切除术35例临床分析 被引量:1

Intraoperative ultrasonography in preventing recurrence after the resection of hepatocellular carcinoma
下载PDF
导出
摘要 目的评价术中B超引导下行肝癌切除术在预防肝癌术后复发的应用价值。方法35例肝癌患者在术中B超引导下行肝癌切除术(A组),另35例行常规肝癌切除术(B组),术后定期复查肝功能、AFP、CT及MRI等,并随访。结果术中B超对直径小于3cm肿瘤检出阳性率为93.1%,直径大于3cm肿瘤检出阳性率为100%。应用术中B超使34.3%(12/35)患者改变了原手术方案。术后5年局部复发率A组为54.3%,B组为88.6%(P<0.05)。结论术中B超对肝癌定位准确,能够提高手术安全性、彻底性和合理性,降低肝癌术后复发率,明显优于常规肝癌切除术。 Objective To evaluate the value of intraoperative ultrasonography(IOUS) in preventing recurrence after the resection of hepatocellular carcinoma. Methods Thirty-five patients underwent the procedure guided by IOUS(group A)and 35 patients underwent conventional resection(group B), AFP,CT and MRI were used regularly ultrasound during the follow-up period to evaluate the outcome. Results The intraoperative ultrasonography could detect 93.1% tumors whose diameters were less than 3cm and detect 100% tumors whose diameters were larger than 3cm. 34.3% patients undergoing resection of primary carcinoma of liver had the planned procedure changed by IOUS, 5-year local recurrence rates were 54.3 % (group A) and 88.6 % (group B). Conclusion Intraoperative hepatic ultrasonography can locate the focus accurately,improve surgical safety,make the operation more radical and decrease the recurrent rat,this is more effective than traditional hepatectomy.
出处 《重庆医学》 CAS CSCD 北大核心 2009年第12期1499-1499,1501,共2页 Chongqing medicine
关键词 肝细胞癌 术中B超 术后复发 hepatocellular carcinoma intraoperative ultrasonography recurrence after the resection
  • 相关文献

参考文献4

二级参考文献30

  • 1Raedle J,Oremek G, Truschnowitsch M, et al. Clinical evaluation of autoantibodies to p53 protein in patients with chronic liver disease and hepatocellular carcinoma[J]. EurJ Cancer, 1998,34 : 1198.
  • 2Charuruks N, Tangkijvanich P, Voravud N, et al. Clinical significance of p53 antigen and anti-p53 antibodies in the sera of hepatocellular carcinoma patients[J]. J Gastroenterol, 2001,36:830.
  • 3Carstens BP, Perry ME. Purification of a fragment of MDM2 for production of polyclonal antisera[J]. Protein Expr Purif,2001,21:361.
  • 4Uchida T,Gao JP,Wang CX,et al. Clinical significance of p53,mdm2,and bcl-2 proteins in renal cell carcinoma[J].Urology,2002,59 :615.
  • 5Endo K, Ueda T, Ohta T, et al. Protein expression of MDM2 and its clinicopathological relationships in human hepatocellular carcinoma[J]. Liver, 2000,20 : 209.
  • 6Sarris M, Lee CS. Nm23 protein expression in colorectal carcinoma metastasis in regional lymph nodes and the liver[J]. Eur J Surg Oncol,2001,27:170.
  • 7Yamaguchi A, Urano T, Goi T, et al. Expression of human nm23-H1 and nm23-H2 protein in hepatocellular carcinoma[J]. Cancer, 1994,73: 2280.
  • 8Sun J J, Zhou XD, Liu YK, et al. Invasion and metastasis of liver cancer: expression of intereellular adhesion moleeule l[J]. J Canecr Res Clin Oncol, 1999,125:28.
  • 9Skubitz Amy PN. Adhesion molecules [J]. Cancer Treat Res, 2002,107 : 305.
  • 10Endo K,Terada T. Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: relationships with tumor grade,clinicopathologic parameters,p53 expression,and patient survival[J]. J Hepatol, 2000,32:78.

共引文献7

同被引文献24

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部